Safety and Efficacy of Carbon Dioxide Gas for Endoscopy
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the safety and effectiveness of using carbon dioxide gas instead of regular air during endoscopy procedures in children. Endoscopy is a medical procedure that allows doctors to look inside the body, often to investigate abdominal pain. The main focus of the study is to see if using carbon dioxide gas makes children more comfortable during the procedure, especially in terms of abdominal pain, gas, and bloating.
The trial is open to infants and children aged 6 months to 18 years who need an endoscopy procedure, such as an upper gastrointestinal scope or colonoscopy. However, certain children, such as those with serious health issues or chronic lung disease, won't be eligible to participate. If a child joins the study, they can expect to be part of a comparison between the two types of gas used during their procedure, helping doctors learn which method is better for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Infants and children 6 months to 18 years undergoing any upper endoscopy related procedure including but not limited to EGD/Colonoscopy, ERCP, EGD only, EUS, EGD with foreign body removal, Enteroscopy.
- Exclusion Criteria:
- • Patients with American Society of Anesthesiology (ASA) Physical Status Classification System of 4 and above
- • Children with chronic lung disease,
- • Children who are wards of the state will be excluded.
- • Children needing language interpreting services that is not Spanish.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported